Estrogen responsiveness of bone formation in vitro and altered bone phenotype in aged estrogen receptor-α-deficient male and female mice

European Journal of Endocrinology

Volumn 152, Issue 2, 2005, Pages 301-314

  Parikka, Vilhelmiina ^a,b   Peng, ZhiQi ^a   Hentunen, Teuvo ^a   Risteli, Juha ^b,c   Elo, Teresa ^a   Väänänen, H Kalervo ^a   Härkönen, Pirkko ^a,d  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; COLLAGEN TYPE 1; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE STRENGTH; CARTILAGE; CELL CULTURE; CELL DIFFERENTIATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GROWTH PLATE; HORMONE RESPONSE; IN VITRO STUDY; KNOCKOUT MOUSE; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEFICIENCY; THICKNESS; TIBIA; TRABECULAR BONE; WILD TYPE;

EID: 14644422263     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01832     Document Type: Article

References (62)

1. Morishima A, Grumbach MM, Simpson ER, Fisher C & Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. Journal of Clinical Endocrinology and Metabolism 1995 80 3689-3698.
2. Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J, Korach KS & Simpson ER. Effect of testosterone and estradiol in a man with aromatase deficiency. New England Journal of Medicine 1997 337 91-95.
3. Öz OK, Zerwekh JE, Fisher C, Graves K, Nanu L, Millsaps R & Simpson ER. Bone has a sexually dimorphic response to aromatase deficiency. Journal of Bone and Mineral Research 2000 15 507-514.
4. Miyaura C, Toda K, Inada M, Ohshiba T, Matsumoto C, Okada T, Ito M, Shizuta Y & Ito A. Sex- and age-related response to aromatase deficiency in bone. Biochemical and Biophysical Research Communications 2001 280 1062-1068.
5. Vanderschueren D, Boonen S, Ederveen AG, de Coster R, Van Herck E, Moermans K, Vandenput L, Verstuyf A & Bouillon R. Skeletal effects of estrogen deficiency as induced by an aromatase inhibitor in an aged male rat model. Bone 2000 27 611-617.
6. Qu Q, Perälä-Heape M, Kapanen A, Dahllund J, Salo J, Väänänen HK & Härkönen P. Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture. Bone 1998 22 201-209.
7. Zhou S, Zilberman Y, Wassermann K, Bain SD, Sadovsky Y & Gazit D. Estrogen modulates estrogen receptor alpha and beta expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice. Journal of Cellular Biochemistry 2001 81 144-155.
8. Gohel A, McCarthy MB & Gronowicz G. Estrogen prevents glucocorticoid-induced apoptosis in osteoblasts in vivo and in vitro. Endocrinology 1999 140 5339-5347.
9. Kousteni S, Bellido, T, Plotkin LI, O'Brien CA, Bodenner DL, Han L, Han K, DiGregorio GB, Katzenellenbogen JA, Katzenellenbogen BS, Roberson PK, Weinstein RS, Jilka RL & Manolagas SC. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 2001 104 719-730.
10. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H & Manolagas SC. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992 257 88-91.
11. Srivastava S, Toraldo G, Weitzmann MN, Cenci S, Ross FP & Pacifici R. Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation. Journal of Biological Chemistry 2001 276 8836-8840.
12. Parikka V, Lehenkari P, Sassi ML, Halleen J, Risteli J, Härkönen P & Väänänen HK. Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts. Endocrinology 2001 142 5371-5378.
13. Bord S, Vedi S, Beavan SR, Horner A & Compston JE. Megakaryocyte population in human bone marrow increases with estrogen treatment: a role in bone remodeling? Bone 2000 27 397-401.
14. Ramalho AC, Couttet P, Baudoin C, Morieux C, Graulet AM, de Vernejoul MC & Cohen-Solal ME. Estradiol and raloxifene decrease the formation of multinucleate cells in human bone marrow cultures. European Cytokine News 2002 13 39-45.
15. Eriksen EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC & Riggs BL. Evidence of estrogen receptors in normal human osteoblast-like cells. Science 1988 241 84-86.
16. Komm BS, Terpening CM, Benz DJ, Graeme KA, Gallegos A, Korc M, Greene GL, O'Malley BW & Haussler MR. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science 1988 241 81-84.
17. Onoe Y, Miyaura C, Ohta H, Nozawa S & Suda T. Expression of estrogen receptor beta in rat bone. Endocrinology 1997 138 4509-4512.
18. Pensler JM, Radosevich JA, Higbee R & Langman CB. Osteoclasts isolated from membranous bone in children exhibit nuclear estrogen and progesterone receptors. Journal of Bone and Mineral Research 1990 5 797-802.
19. Oursler MJ, Osdoby P, Pyfferoen J, Riggs BL & Spelsberg TC. Avian osteoclasts as estrogen target cells. PNAS 1991 88 6613-6617.
20. Huang WH, Lau AT, Daniels LL, Fujii H, Seydel U, Wood DJ, Papadimitriou JM & Zheng MH. Detection of estrogen receptor alpha, carbonic anhydrase II and tartrate-resistant acid phosphatase mRNAs in putative mononuclear osteoclast precursor cells of neonatal rats by fluorescence in situ hybridization. Journal of Molecular Endocrinology 1998 20 211-219.
21. Oreffo RO, Kusec V, Virdi AS, Flanagan AM, Grano M, Zambonin-Zallone A & Triffitt JT. Expression of estrogen receptor-alpha in cells of the osteoclastic lineage. Histochemistry and Cell Biology 1999 111 125-133.
22. Collier FM, Huang WH, Holloway WR, Hodge JM, Gillespie MT, Daniels LL, Zheng MH & Nicholson GC. Osteoclasts from human giant cell tumors of bone lack estrogen receptors. Endocrinology 1998 139 1258-1267.
23. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn D & Korach KS. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. New England Journal of Medicine 1994 331 1056-1061.
24. Dieudonne SC, Xu T, Chou JY, Kuznetsov SA, Satomura K, Mankani M, Fedarko NS, Smith EP, Robey PG & Young MF. Immortalization and characterization of bone marrow stromal fibroblasts from a patient with a loss of function mutation in the estrogen receptor-alpha gene. Journal of Bone and Mineral Research 1998 13 598-608.
25. Lindberg MK, Weihua Z, Andersson N, Moverare S, Gao H, Vidal O, Erlandsson M, Windahl S, Andersson G, Lubahn DB, Carlsten H, Dahlman-Wright K, Gustafsson JA & Ohlsson C. Estrogen receptor specificity for the effects of estrogen in ovariectomized mice. Journal of Endocrinology 2002 174 167-178.
26. Sims NA, Clement-Lacroix P, Minet D, Fraslon-Vanhulle C, Gaillard-Kelly M, Resche-Rigon M & Baron R. A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice. Journal of Clinical Investigation 2003 111 1319-1327.
27. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS & Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. PNAS 1993 90 11162-11166.
28. Couse JF & Korach KS. Estrogen receptor null mice: what have we learned and where will they lead us? Endocrine Reviews 1999 20 358-417.
29. Wronski TJ, Lowry PL, Walsh CC & Ignaszewski LA. Skeletal alterations in ovariectomized rats. Calcified Tissue International 1985 37 324-328.
30. Lindberg MK, Alatalo SL, Halleen JM, Mohan S, Gustafsson JA & Ohlsson C. Estrogen receptor specificity in the regulation of the skeleton in female mice. Journal of Endocrinology 2001 171 229-236.
31. Vandenput L, Ederveen AG, Erben RG, Stahr K, Swinnen JV, Van Herck E, Verstuyf A, Boonen S, Bouillon R & Vanderschueren D. Testosterone prevents orchidectomy-induced bone loss in estrogen receptor-alpha knockout mice. Biochemical and Biophysical Research Communications 2001 285 70-76.
32. Sims NA, Dupont S, Krust A, Clement-Lacroix P, Minet D, Resche-Rigon M, Gaillard-Kelly M & Baron R. Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males. Bone 2002 30 18-25.
33. McDougall KE, Perry MJ, Gibson RL, Colley SM, Korach KS & Tobias JH. Estrogen receptor-alpha dependency of estrogen's stimulatory action on cancellous bone formation in male mice. Endocrinology 2003 144 1994-1999.
34. Lindberg MK, Moverare S, Skrtic S, Alatalo S, Halleen J, Mohan S, Gustafsson JA & Ohlsson C. Two different pathways for the maintenance of trabecular bone in adult male mice. Journal of Bone and Mineral Research 2002 17 555-562.
35. Lee K, Jessop H, Suswillo R, Zaman G & Lanyon L. Endocrinology: bone adaptation requires oestrogen receptor-alpha. Nature 2003 424 389.
36. Vidal O, Lindberg MK, Hollberg K, Baylink DJ, Andersson G, Lubahn DB, Mohan S, Gustafsson JA & Ohlsson C. Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. PNAS 2000 97 5474-5479.
37. Peng Z, Tuukkanen J, Zhang H, Jämsä T & Väänänen HK. The mechanical strength of bone in different rat model of experimental osteoporosis. Bone 1994 15 523-532.
38. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM & Recker RR. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. Journal of Bone and Mineral Research 1987 2 595-610.
39. Rulli SB, Kuorelahti A, Karaer O, Pelliniemi LJ, Poutanen M & Huhtaniemi I. Reproductive disturbances, pituitary lactotrope adenomas, and mammary gland tumors in transgenic female mice producing high levels of human chorionic gonadotropin. Endocrinology 2002 143 4084-4095.
40. Boyde A, Ali NN & Jones SJ. Resorption of dentine by isolated osteoclasts in vitro. British Dental Journal 1984 156 216-220.
41. Chambers TJ, Revell PA, Fuller K & Athanasou NA. Resorption of bone by isolated rabbit osteoclasts. Journal of Cell Science 1984 66 383-399.
42. Lakkakorpi P, Tuukkanen J, Hentunen T, Järvelin K & Väänänen K. Organization of osteoclast microfilaments during the attachment to bone surface in vitro. Journal of Bone and Mineral Research 1989 4 817-825.
43. Selander K, Lehenkari P & Väänänen HK. The effects of bisphosphonates on the resorption cycle of isolated osteoclasts. Calcified Tissue International 1994 55 368-375.
44. Chomczynsky P & Sacchi N. Single-step method of RNA isolation by acid guanidium-thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 1987 162 156-159.
45. Ohlsson C, Hellberg N, Parini P, Vidal O, Bohlooly M, Rudling M, Lindberg MK, Warner M, Angelin B & Gustafsson JA. Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochemical and Biophysical Research Communications 2000 278 640-645.
46. Whipple T, Sharkey N, Demers L & Williams N. Leptin and the skeleton. Clinical Endocrinology 2002 57 701-711.
47. Vidal O, Lindberg M, Savendahl L, Lubahn DR, Ritzen EM, Gustafsson JA & Ohlsson C. Disproportional body growth in female estrogen receptor-alpha-inactivated mice. Biochemical and Biophysical Research Communications 1999 265 569-571.
48. Chagin AS, Lindberg MK, Andersson N, Moverare S, Gustafsson JA, Savendahl L & Ohlsson C. Estrogen receptor-beta inhibits skeletal growth and has the capacity to mediate growth plate fusion in female mice. Journal of Bone and Mineral Research 2004 19 72-77.
49. van der Eerden BC, Karperien M & Wit JM. Systemic and local regulation of the growth plate. Endocrine Reviews 2003 24 782-801.
50. Manolagas SC, Kousteni S & Jilka RL. Sex steroids and bone. Recent Progress in Hormone Research 2002 57 385-409.
51. Couse JF, Curtis SW, Washburn TF, Lindzey J, Golding TS, Lubahn DB, Smithies O & Korach KS. Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Molecular Endocrinology 1995 9 1441-1454.
52. Denger S, Reid G, Kos M, Flouriot G, Parsch D, Brand H, Korach KS, Sonntag-Buck V & Gannon F. ERalpha gene expression in human primary osteoblasts: evidence for the expression of two receptor proteins. Molecular Endocrinology 2001 15 2064-2077.
53. McCauley LK, Tozum TF, Kozloff KM, Koh-Paige AJ, Chen C, Demashkieh M, Cronovich H, Richard V, Keller ET, Rosol TJ & Goldstein SA. Transgenic models of metabolic bone disease: impact of estrogen receptor deficiency on skeletal metabolism. Connective Tissue Research 2003 44 250-263.
54. McDougall KE, Perry MJ, Gibson RL, Bright JM, Colley SM, Hodgin JB, Smithies O & Tobias JH. Estrogen-induced osteogenesis in intact female mice lacking ERbeta. American Journal of Physiology. Endocrinology and Metabolism 2002 283 E817-E823.
55. Windahl SH, Vidal O, Andersson G, Gustafsson JÅ & Ohlsson C. Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice. Journal of Clinical Investigation 1999 104 895-901.
56. Windahl SH, Hollberg K, Vidal O, Gustafsson JÅ, Ohlsson C & Andersson G. Female estrogen receptor beta -/- mice are partially protected against age-related trabecular bone loss. Journal of Bone and Mineral Research 2001 16 1388-1398.
57. Ke HZ, Qi H, Crawford DT, Simmons HA, Zhang Q, Brown TA, Petersen DN, Jee WSS & Thompson DD. Improved survival rate and bone status in senile female mice lacking estrogen receptor-beta. Journal Bone and Mineral Res 2002 17 (suppl.) S133.
58. Bonnelye E, Merdad L, Kung V & Aubin JE. The orphan nuclear estrogen receptor-related receptor alpha (ERRalpha) is expressed throughout osteoblast differentiation and regulates bone formation in vitro. Journal of Cell Biology 2001 153 971-984.
59. Giguere V. To ERR in the estrogen pathway. Trends in Endocrinology and Metabolism 2002 13 220-225.
60. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D & Chambon P. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 1995 270 1491-1494.
61. Lee AV, Cui X & Oesterreich S. Cross-talk among estrogen receptor, epidermal growth factor, and insulin-like growth factor signaling in breast cancer. Clinical Cancer Research 2001 7 4429S-4435S.
62. Ciana P, Raviscioni M, Mussi P, Vegeto E, Que I, Parker MG, Lowik C & Maggi A. In vivo imaging of transcriptionally active estrogen receptors. Nature Medicine 2003 9 82-86.